Disclosure of Transfers of Value from Colonis Pharma Limited to Healthcare Professionals and Healthcare Organisations

Colonis Pharma Limited has agreed to comply with the Association of the British Pharmaceutical Industry‘s (ABPI) Code of Practice and to accept the jurisdiction of the Prescription Medicines Code of Practice Authority (PMCPA). The PMCPA operate the Code of Practice for the Pharmaceutical Industry, independently of the ABPI.

Annually, all payments made by Colonis to UK healthcare professionals (HCPs) and healthcare organisations (HCOs) during the previous calendar year will be disclosed on a searchable and publicly accessible central database on the ABPI website known as Disclosure UK, accessed via the following web address:

www.disclosureuk.org.uk.

In accordance with the Code, Colonis discloses transfers of value connected to the development and commercialisation of prescription-only human pharmaceuticals to HCPs and HCOs.

The disclosed data include transfers of value in four main categories:

Category of ToV HCPs HCOs
Donations and Grants N/A Each payment amount per HCO, whether monetary or other
Contribution to cost of events Registration fees, travel and accommodation Yearly amount per HCP Sponsorship agreements, Registration fees, travel and accommodation Each payment amount per HCO
Fees for Service and Consultancy Fees
Yearly amount per HCP
Fees
Each payment amount per HCO
Expenses related to fees
Yearly amount per HCP
Expenses related to fees
Each payment amount per HCO
Research and Development Aggregate amount for HCP Aggregate amount for HCO

As required by the ABPI Code of Practice, pharmaceutical companies must make publicly available a list of patient organisations to which they provide financial support and/or significant indirect/non-financial support.

 

 

Disclosure of Payments from 2017

Disclosure of Payments from 2017

Colonis is proud to have supported the work of the following  UK professional and patient-support organisations in 2017

Macmillan Cancer Support
Macmillan Coffee Morning £200

Naomi House and Jacksplace
Donation £375

St Michael’s Hospice (North Hampshire)
Donation £375

 

Disclosure of Payments from 2015

Disclosure of Payments from 2015

The Colonis Pharma products available to the UK market during 2015 were predominantly medical devices and one licensed pharmaceutical product. During 2015 there were no transfers of value in relation to the pharmaceutical product that was on the market. Colonis have determined that it is best practice to apply the principles of 'disclosure of transfers of value' to their activities in respect of medical devices. Disclosure for medical devices has been made at an aggregate level.

During 2015 Colonis made transfers of value in respect of their medical devices in the following areas:

  • Sponsorship for meeting attendance (to cover registration fees, travel and accommodation)
  • Grants
  • Benefits in kind

These have been disclosed at an aggregate level in the template produced by the ABPI which is located here. This information will remain in the public domain for 3 years, and be retained by Colonis for 5 years after the calendar year to which it relates.